Chapter 17 : Host Susceptibility

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Host Susceptibility, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818364/9781555810672_Chap17-1.gif /docserver/preview/fulltext/10.1128/9781555818364/9781555810672_Chap17-2.gif


In this chapter, the term cholera gravis will denote the most severe life-threatening form of the disease, which can be rapidly fatal without treatment. One of the clear messages about cholera is that if the environment is made safer by sound sanitary practices and if good personal hygiene is put in place, the disease largely goes away. Anti-cholera toxin binding (CTB) antibody titers in contact with children's saliva were used to correlate their immune responses to CTB vaccination with nutritional status as part of the intervention arm of the family study mentioned in the chapter. The cholera attack rates were 88% in the heavy users of cannabis and 37% in light users. Because of the extensive use of cannabis-containing products in many areas where cholera is endemic, habitual usage may be a factor in host susceptibility where the risk of intake of contaminated food and water is high. The molecular genetic basis for the group ABO system was elucidated by Yamamoto, who suggested that the ABO markers be designated a histo-blood system, since the genes and their products are also found in many other cell types, e.g., epithelial cells. At present, two major attachment systems are known to be involved in adherence and colonization of animals and humans. The toxin-coregulated pilis (TCPs) share 80% amino acid homology at the amino acid level.

Citation: Richardson S. 1994. Host Susceptibility, p 273-289. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch17
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


1. Barra, J. L.,, C. G. Monferran,, L. E. Balanzino, and E A. Cumar. 1992. Escherichia coli heat-labile enterotoxin preferentially interacts with blood group A-active glycolipids from pig intestinal mucosa and A- and B-active glycolipids from human red cells compared to H-active glycolipids. Mol. Cell. Biochem. 115: 63 70.
2. Barua, D.,, and A. S. Paguio. 1977. ABO blood groups and cholera. Ann. Hum. Biol. 4: 489 492.
3. Bennun, E. R.,, G. A. Roth,, C. G. Monferran,, and F. A. Cumar. 1989. Binding of cholera toxin to pig intestinal mucosa glycosphingolipids: relationship with the ABO blood group system. Infect, lmmun. 57: 969 974.
4. Cater, R. E.,, n. 1992. Helicobacter (aka Campylobacter) pylori as the major causal factor in chronic hypochlorhydria. Med. Hypoth. 39: 367 374.
5. Chaudhuri, A.,, and S. De. 1977. Cholera and blood-groups. Lancet ii: 404.
6. Clemens, J. D.,, D. A. Sack,, J. R. Harris,, J. Chakraborty,, M. R. Khan,, S. Huda,, F. Ahmed,, J. Gomes,, M. R. Rao,, A.-M. Svennerholm,, and J. Holmgren. 1989. ABO blood groups and cholera: new observations on specificity of risk and modification of vaccine efficacy. J. Infect. Dis. 159: 770 773.
7. Clemens, J. D.,, D. A. Sack,, J. R. Harris,, M. R. Khan,, J. Chakraborty,, S. Chowdhury,, M. R. Rao,, F. R. van Loon,, B. E. Stanton,, M. Yunus,, M. Ali,, M. Ansaruzzaman,, A.-M. Svennerholm,, and J. Holmgren. 1990. Breast feeding and the risk of severe cholera in rural Bangladeshi children. Am. J. Epidemiol. 131: 400 411.
8. Cover, T. L.,, S. G. Vaughn,, and P. Cao. 1992. Potentiation of Helicobacter pylori vacuolating toxin activity by nicotine and other weak bases. J. Infec. Dis. 166: 1073 1078.
9. Donta, S. T.,, T. Tomicle,, and R. K. Holmes. 1992. Binding of class U Escherichia coli enterotoxins to mouse Yl and intestinal cells. Infect. Immun. 60: 2870 2873.
10. Dubey, R. S.,, M. Lindblad,, and J. Holmgren. 1990. Purification of El Tor cholera enterotoxins and comparisons with classical toxin. J. Gen. Microbiol. 136: 1839 1847.
11. Elson, C. O. 1992. Cholera toxin as a mucosal adjuvant: effects of H-2 major histocompatibility complex and Ips genes. Infect. Immun. 60: 2874 2879.
12. Elson, C. O.,, and W. Ealding. 1985. Genetic control of the murine immune response to cholera toxin. J. Immunol. 135: 930 932.
13. Elson, C. O.,, and W. Ealding. 1987. Ir gene control of the murine secretory IgA response to cholera toxin. Eur. J. Immunol. 17: 425 428.
14. Ernst, L. K.,, V. P. Rajan,, R. D. Larsen,, M. M. Ruff,, and J. B. Lowe. 1989. Stable expression of blood group H determinants and GDP-L-fucose: beta-D-galactoside 2-alpha-L-fucosyltransferase in mouse cells after transfection with human DNA. J. Biol. Chem. 264: 3436 3447.
15. Finkelstein, R. A.,, M. Boesman-Finkelstein,, Y. Chang,, and C. C. Hase. 1992. Vibrio cholerae hemagglutinin/protease, colonial variation, virulence, and detachment. Infect. Immun. 60: 472 478.
16. Galen, J. J.,, A. Ketley,, A. Fasano,, S. Richardson,, S. Wasserman,, and J. Kaper. 1992. Role of Vibrio cholerae neuraminidase in the function of cholera toxin. Infect. Immun. 60: 406 415.
17. Glass, R. I.,, J. Holmgren,, C. E. Haley,, M. R. Khan,, A.-M. Svennerholm,, B. J. Stoll,, K. M. B. Hossain,, R. E. Black,, M. Yunus,, and D. Barua. 1985. Predisposition for cholera of individuals with O blood group. Am. J. Epidemiol. 121: 791 796.
18. Glass, R. I.,, J. Holmgren,, M. R. Khan,, K. M. B. Hossain,, M. I. Huq,, and W. B. Greenough. 1984. A randomized, controlled trial of the toxin-blocking effects of B Subunit in family members of patients with cholera. J. Infect. Dis. 149: 495 500.
19. Glass, R. I.,, A.-M. Svennerholm,, M. R. Khan,, S. Huda,, M. I. Huq,, and J. Holmgren. 1985. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection. J. Infect. Dis. 151: 236 242.
20. Glass, R. I.,, A. M. Svennerholm,, B. J. Stoll,, M. R. Khan,, S. Huda,, and M. I. Huq. 1989. Effects of undernutrition on infection with Vibrio cholerae O1 and on response to oral cholera vaccine. Pediatr. Infect. Dis. J. 8: 105 109.
21. Hakomori, S. 1991. Immunochemical and molecular genetic basis of the histo-blood group ABO(H) and related antigen system. Baillieres C lin. Haematol. 4: 957 974.
22. Hall, R. H.,, G. Losonsky,, A. R D. Silveira, R. K. Taylor, J. J. Mekalanos, N. D. Witham, and M. M. Levine. 1991. Immunogenicity of Vibrio cholerae O1 toxin-coregulated pili in experimental and clinical cholera. Infect. Immun. 59: 2508 2512.
22a. Hashimoto, Y.,, A. Suzuki,, T. Yamakawa,, N. Miwashita,, and K. Moriwaki. 1983. Expression of GM1 and GDI a in mouse liver is linked to the H-2 complex on chromosome 17. J. Biochem. 94: 2043 2048.
23. Holgersson, J.,, N. Strdmberg,, and M. E. Breimer. 1988. Glycolipids of human large intestine: difference in glycolipid expression related to anatomical localization, epithelial/non-epithelia tissue and the ABO, Le and Se phenotypes of the donors. Biochimie 70: 1565 1574.
24. Jonson, G.,, J. Holmgren,, and A.-M. Svennerholm. 1991. Epitope differences in toxin-coregulated pili produced by classical and El Tor Vibrio cholerae O1. Microb. Pathog. 11: 179 188.
25. Johnson, G.,, J. Holmgren,, and A.-M. Svennerholm. 1991. Identification of a mannose-binding pilus on Vibrio cholerae El Tor. Microb. Pathog. 11: 433 441.
26. Jonson, G.,, J. Holmgren,, and A.-M. Svennerholm. 1992. Analysis of expression of toxin-coregulated pili in classical and El Tor Vibrio cholerae O1 in vitro and in vivo. Infect. Immun. 60: 4278 4284.
27. Kaper, J. Personal communication.
28. Katelaris, P. H.,, G. H. K. Hppett,, P. Norbu,, D. G. Lowe,, R. Brennan,, and M. J. G. Farthing. 1992. Dyspepsia, Helicobacter pylori, and peptic ulcer in a randomly selected population in India. Gut 33: 1462 1466.
29. Lange, S.,, and I. Lonnroth. 1986. Bile and milk from cholera toxin treated rats contain a hormonelike factor which inhibits diarrhea induced by the toxin. Int. Arch. Allergy Appl. Immunol. 79: 270 275.
30. Levine, M. M.,, D. R. Nalin,, M. B. Rennels,, R. B. Hornick,, S. Sotman,, G. Van Blerk,, T. P. Hughes,, S. O'DonneU,, and D. Barua. 1979. Genetic susceptibility to cholera. 6: 369 374.
31. Mandel, U.,, T. White,, J. Karkov,, S. Hakomori,, H. Clausen,, and E. Dabelsteen. 1990. Expression of the histo-blood group ABO gene defined gly-cosyltransferases in epithelial tissues. J. Oral Pathol. Med. 19: 251 256.
32. Moyenuddin, M.,, K. Wachsmuth,, S. H. Richardson,, and W. L. Cook. 1992. Enteropatho-genicity of non-toxigenic Vibrio cholerae O1 for adult mice. Microb. Pathog. 12: 451 458.
33. Nalin, D. R.,, M. M. Levine,, E. Bergquist,, J. Libonati,, R. J. Levine,, D. Hoover,, J. McLaughlin,, J. Alam,, and R. B. Hornick. 1978. Cholera, non-vibrio cholera, and stomach acid. Lancet ii: 856 859.
34. Nalin, D. R.,, J. Rhead,, M. Rennels,, S. O'DonneU,, M. M. Levine,, E. Bergquist,, T. Hughes,, and R. B. Hornick. 1978. Cannabis, hypo-chlorhydria, and cholera. Lancet ii: 859 862.
35. Odelgah, P. G. 1990. Influences of blood group and secretor genes on susceptibility to duodenal ulcer. EastAfr. Med. J. 67: 487 500.
36. Oriol, R.,, R. Mollicone,, P. Coulin,, A. M. Dalix,, and J. J. Candelier. 1992. Genetic regulation of the expression of ABH and Lewis antigens in tissues. APMISSuppl. 27: 28 38.
37. Palmer, D. L.,, and S. N. Zaman. 1979. Depression of cell-mediated immunity in cholera. Infect. Immun. 23: 27 30.
38. Ramirez-Ramos, A.,, R. Gilman,, W. Spira,, S. Recavarren,, J. Watanabe,, R. Leon-Barua,, C. Rodriguez,, C. Guevara,, G. Gago,, J. Bonilla,, J. Cok,, H. Huidobro Ruiz,, E. Gomez,, E. Olivares,, R. Garcia,, G. Garrido Klinge,, G. Vargas,, M. Astete,, M. Valdivia,, and R. Berendson. 1992. Ecology of Helicobacter pylori in Peru: infection rates in coastal, high altitude, and jungle communities. Gut 33: 604 605.
39. Richardson, S. H.,, J. C. Giles,, and K. S. Kruger. 1984. Sealed adult mice: a new model for enterotoxin evaluation. Infect. Immun. 43: 482 486.
40. Richardson, S. H.,, and J. V. Kaspar,. 1990. Genetic studies on V. fluvialis and its enterotoxins, p. 159 171. In A. E. Pohland et al. (ed.), Microbial, Toxins in Foods and Feeds. Plenum Press, New York.
41. Richardson, S. H.,, M. Kothary,, and T. Sexton,. 1990. H-2 regulated responses to enterotoxins in isolated cells, cell lysates and membranes, p. 235 246. In Y. Zinnaka, and R. B. Sack (ed.), Advances in Research on Cholera and Related Diarrheas, vol. 7. KTK Scientific Publishers, Tokyo.
42. Richardson, S. H.,, R. Kuhn,, J. Estrada,, M. J. Black,, and D. Pardi,. 1988. In vivo and in vitro studies on the genetic and cellular control of the response to cholera toxin in inbred mice, p. 297 306. In S. Kuwahara, and N. Pierce (ed.), Advances in Research on Cholera and Related Diarrheas, vol. 5. KTK Scientific Publishers, Tokyo.
43. Richardson, S. H.,, and R. E. Kuhn,. 1986. H-2 modulation of cholera enterotoxin effects in SAM: (sealed adult mice), p. 305 316. In S. Kuwahara, and N. F. Pierce (ed.), Advances in Research on Cholera and Related Diarrheas, vol. 3. KTK Scientific Publishers, Tokyo.
44. Richardson, S. H.,, and R. E. Kuhn. 1986. Studies on the genetic and cellular control of sensitivity to enterotoxins in the sealed adult mouse model. Infect. Immun. 54: 522 528.
45. Richardson, S. H.,, T. Sexton,, J. Rader,, and C. Kajs. 1993. The biochemical and genetic basis for the ETS (enterotoxin sensitivity) phenotype in mice. Clin. Infect. Dis. 16( Suppl. 2): S83 S91.
46. Richardson, S. H.,, T. Y. Sexton,, C. Kajs,, and J. Rader,. The enterotoxin sensitivity phenotype (ETS) is controlled by host cell ganglioside composition. In Y. Takeda, and R. B. Sack (ed.), Advances in Research on Cholera and Related Diarrheas, vol. 9, in press. KTK Scientific Publishers, Tokyo.
47. Rodman, D. M.,, and S. Zamudio. 1991. The cystic fibrosis heterozygote—advantage in surviving cholera? Med. Hypoth. 36: 253 258.
48. Sheinfeld, J.,, A. J. Schaffer,, C. Cordon-Cardo,, A. Ragatko,, and W. R. Fair. 1989. Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. N. Engl. J. Med. 320: 773 777.
49. Sircar, B. K.,, P. Dutta,, S. P. De,, S. N. Sikdar,, B. C. Deb,, and S. C. Pal. 1981. ABO blood group distributions in diarrhoea cases including cholera in Calcutta. Ann. Hum. Biol. 8: 289 291.
50. Sugarman, B.,, and S. T. Donta. 1979. Specificity of attachment of certain enterobacteriaccae to mammalian cells. J. Gen. Microbiol. 115: 509 512.
51. van Loon, F. P.,, J. D. Clemens,, M. Shahrier,, D. A. Sack,, C. B. Stephen,, M. R. Khan,, G. H. Rabbani,, M. R. Rao,, and A. K. Banik. 1990. Low gastric acid as a risk factor for cholera transmission: application of a new non-invasive gastric acid field test. J. Clin. Epidemiol. 43: 1361 1367.
52. Walser, B. L.,, R. D. Newman,, A. A. M. Lima,, and R. L. Guerrant. 1992. Pathogen and host differences in bacterial adherence to human buccal epithelial cells in a northeast Brazilian community. Infect. Immun. 60: 4793 4800.
53. Yamamoto, F.,, H. Clausen,, T. White,, J. Marken,, and S. Hakomori. 1900. Molecular genetic basis of the histo-blood group ABO system. Nature (London) 345: 229 233.


Generic image for table
Table 1

Evidence linking cholera severity to ABO blood type

Citation: Richardson S. 1994. Host Susceptibility, p 273-289. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch17
Generic image for table
Table 2

CT binding and cAMP accumulation in ETS and ETS cell lines

Citation: Richardson S. 1994. Host Susceptibility, p 273-289. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch17
Generic image for table
Table 3

Effects of preincubation with neuraminidase, LT Da, and LT lib on CT-induced cAMP accumulation in ETS and ETS transformed cells

Citation: Richardson S. 1994. Host Susceptibility, p 273-289. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch17

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error